VR Logo

Vapotherm Inc. (VAPO) download report

Healthcare | Medical Devices & Equipment

Vapotherm Inc. (VAPO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.

IPO Date: 14-Nov-2018

CEO, Pres & Director: Mr. Joseph F. Army CPA, CPA

Sr. VP, CFO & Treasurer: Mr. John Landry

Listing: NYSE: VAPO

Country: United States

Headquarters: Exeter, NH

Website: https://www.vapotherm.com

Key Facts

Market cap: $83.94 Mln

Revenue (TTM): $102.61 Mln

Earnings (TTM): $-72.33 Mln

Cash: $72.91 Mln

Total Debt: $98.55 Mln

Insider's Holding: 11.02%

Liquidity: Low

52 Week range: $2.46 - 31.87

Shares outstanding: 26,563,500

6 Years Aggregate:

  • CFO: $-229.08 Mln
  • EBITDA: $-222.06 Mln
  • Net Profit: $-258.91 Mln

Stock Performance

Time Period Vapotherm (VAPO) S&P BSE Sensex S&P Small-Cap 600
1 month0.99-2.01-4.75
3 months-78.35-7.32-12.65
1 Year-86.930.45-16.28
3 Years-47.3610.328.01
5 Years--11.296.35
10 Years--12.1410.55
As on 27-Jun-2022
Year Vapotherm (VAPO) S&P Small-Cap 600 S&P BSE Sensex